Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
319
-
Total 13F shares, excl. options
-
54.2M
-
Shares change
-
-420K
-
Total reported value, excl. options
-
$7.3B
-
Value change
-
-$66.7M
-
Put/Call ratio
-
2.92
-
Number of buys
-
145
-
Number of sells
-
-141
-
Price
-
$134.65
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q4 2017
382 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q4 2017.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 319 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.2M shares
.
Largest 10 shareholders include PUTNAM INVESTMENTS LLC (8.27M shares), FMR LLC (6.89M shares), Vanguard Group Inc (4.77M shares), BlackRock Inc. (2.81M shares), Bank of New York Mellon Corp (1.76M shares), JPMORGAN CHASE & CO (1.52M shares), Senator Investment Group LP (1.4M shares), CADIAN CAPITAL MANAGEMENT, LP (1.29M shares), RENAISSANCE TECHNOLOGIES LLC (1.24M shares), and WESTFIELD CAPITAL MANAGEMENT CO LP (1.23M shares).
This table shows the top 319 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.